Sirona Biochem Corp. (CVE:SBM – Get Free Report) was down 16.7% during mid-day trading on Tuesday . The stock traded as low as C$0.05 and last traded at C$0.05. Approximately 113,000 shares were traded during trading, an increase of 91% from the average daily volume of 59,069 shares. The stock had previously closed at C$0.06.
Sirona Biochem Stock Down 9.1 %
The stock has a market cap of C$12.84 million, a price-to-earnings ratio of -5.00 and a beta of -0.03. The firm’s fifty day moving average price is C$0.06 and its two-hundred day moving average price is C$0.06. The company has a debt-to-equity ratio of 219.21, a current ratio of 0.34 and a quick ratio of 2.41.
Sirona Biochem Company Profile
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program.
Recommended Stories
- Five stocks we like better than Sirona Biochem
- Investing in Travel Stocks Benefits
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- Investing in Construction Stocks
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- What Makes a Stock a Good Dividend Stock?
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Sirona Biochem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sirona Biochem and related companies with MarketBeat.com's FREE daily email newsletter.
